Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial
Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 replacing the previous v3.3.3 on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA consolidated Locations section has been added listing Alabama, California, Colorado, Texas, Utah, Virginia, and Washington under a single header, replacing the previous separate location blocks. The page shows Revision: v3.3.3, and older items like HHS Vulnerability Disclosure and individual state location blocks have been removed.SummaryDifference0.9%

- Check55 days agoChange DetectedThe page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the government funding lapse notice and operating status information visible on the page. Core trial details, inclusion criteria, and study results remain unchanged.SummaryDifference0.4%

- Check77 days agoChange DetectedBetween the old and new screenshots, core study details such as status, enrollment, locations, and outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check105 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference5%

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.